Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Feb;79(3-4):456–463. doi: 10.1038/sj.bjc.6690071

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk

N Siegelmann-Danieli 1,2, K H Buetow 1,3
PMCID: PMC2362434  PMID: 10027313

Abstract

The activity of the aromatase enzyme, which converts androgens into oestrogens and has a major role in regulating oestrogen levels in the breast, is thought to be a contributing factor in the development of breast cancer. We undertook this study to assess the role of constitutional genetic variation in the human aromatase gene (Cyp19) in the development of this disease. Our genotyping of 348 cases with breast cancer and 145 controls (all Caucasian women) for a published tetranucleotide repeat polymorphism at intron 4 of the Cyp19 gene revealed the presence of six common and two rare alleles. Contingency table analysis revealed a significant difference in allelic distribution between cases and controls (χ2 5df = 13.52, P = 0.019). The allele measuring 171 bp was over-represented in cases; of 14 individuals homozygous for this allele, 13 were cases. These individuals had a higher incidence of cancer in family members and an earlier age at diagnosis than other cases. In sequencing Cyp19's coding exons and regulatory regions, we discovered a perfect association between a silent polymorphism (G→A at Val80) and the high-risk genotype. Our conclusion is that constitutional genetic variation at the Cyp19 locus is associated with the risk of developing breast cancer, with the 171-bp allele serving as the high-risk allele. © 1999 Cancer Research Campaign

Keywords: breast cancer, aromatase gene, oestrogens, Cyp19

Full Text

The Full Text of this article is available as a PDF (269.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agarwal V. R., Bulun S. E., Leitch M., Rohrich R., Simpson E. R. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J Clin Endocrinol Metab. 1996 Nov;81(11):3843–3849. doi: 10.1210/jcem.81.11.8923826. [DOI] [PubMed] [Google Scholar]
  2. Berrino F., Muti P., Micheli A., Bolelli G., Krogh V., Sciajno R., Pisani P., Panico S., Secreto G. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 1996 Mar 6;88(5):291–296. doi: 10.1093/jnci/88.5.291. [DOI] [PubMed] [Google Scholar]
  3. Brook J. D., McCurrach M. E., Harley H. G., Buckler A. J., Church D., Aburatani H., Hunter K., Stanton V. P., Thirion J. P., Hudson T. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell. 1992 Feb 21;68(4):799–808. doi: 10.1016/0092-8674(92)90154-5. [DOI] [PubMed] [Google Scholar]
  4. Durgam V. R., Tekmal R. R. The nature and expression of int-5, a novel MMTV integration locus gene in carcinogen-induced mammary tumors. Cancer Lett. 1994 Dec 9;87(2):179–186. doi: 10.1016/0304-3835(94)90220-8. [DOI] [PubMed] [Google Scholar]
  5. Fu Y. H., Kuhl D. P., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S., Verkerk A. J., Holden J. J., Fenwick R. G., Jr, Warren S. T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991 Dec 20;67(6):1047–1058. doi: 10.1016/0092-8674(91)90283-5. [DOI] [PubMed] [Google Scholar]
  6. Green M., Krontiris T. G. Allelic variation of reporter gene activation by the HRAS1 minisatellite. Genomics. 1993 Aug;17(2):429–434. doi: 10.1006/geno.1993.1343. [DOI] [PubMed] [Google Scholar]
  7. Harada N. Cloning of a complete cDNA encoding human aromatase: immunochemical identification and sequence analysis. Biochem Biophys Res Commun. 1988 Oct 31;156(2):725–732. doi: 10.1016/s0006-291x(88)80903-3. [DOI] [PubMed] [Google Scholar]
  8. Harada N., Ogawa H., Shozu M., Yamada K., Suhara K., Nishida E., Takagi Y. Biochemical and molecular genetic analyses on placental aromatase (P-450AROM) deficiency. J Biol Chem. 1992 Mar 5;267(7):4781–4785. [PubMed] [Google Scholar]
  9. Harada N., Yamada K., Saito K., Kibe N., Dohmae S., Takagi Y. Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem Biophys Res Commun. 1990 Jan 15;166(1):365–372. doi: 10.1016/0006-291x(90)91954-q. [DOI] [PubMed] [Google Scholar]
  10. Honda S., Harada N., Takagi Y. Novel exon 1 of the aromatase gene specific for aromatase transcripts in human brain. Biochem Biophys Res Commun. 1994 Feb 15;198(3):1153–1160. doi: 10.1006/bbrc.1994.1163. [DOI] [PubMed] [Google Scholar]
  11. James V. H., McNeill J. M., Lai L. C., Newton C. J., Ghilchik M. W., Reed M. J. Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids. 1987 Jul-Sep;50(1-3):269–279. doi: 10.1016/0039-128x(83)90077-6. [DOI] [PubMed] [Google Scholar]
  12. Kennedy G. C., German M. S., Rutter W. J. The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription. Nat Genet. 1995 Mar;9(3):293–298. doi: 10.1038/ng0395-293. [DOI] [PubMed] [Google Scholar]
  13. Krontiris T. G., Devlin B., Karp D. D., Robert N. J., Risch N. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med. 1993 Aug 19;329(8):517–523. doi: 10.1056/NEJM199308193290801. [DOI] [PubMed] [Google Scholar]
  14. Krontiris T. G., DiMartino N. A., Colb M., Parkinson D. R. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. 1985 Jan 31-Feb 6Nature. 313(6001):369–374. doi: 10.1038/313369a0. [DOI] [PubMed] [Google Scholar]
  15. Kunst C. B., Warren S. T. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell. 1994 Jun 17;77(6):853–861. doi: 10.1016/0092-8674(94)90134-1. [DOI] [PubMed] [Google Scholar]
  16. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., Neville C., Narang M., Barceló J., O'Hoy K. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science. 1992 Mar 6;255(5049):1253–1255. doi: 10.1126/science.1546325. [DOI] [PubMed] [Google Scholar]
  17. Means G. D., Kilgore M. W., Mahendroo M. S., Mendelson C. R., Simpson E. R. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol Endocrinol. 1991 Dec;5(12):2005–2013. doi: 10.1210/mend-5-12-2005. [DOI] [PubMed] [Google Scholar]
  18. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Polymeropoulos M. H., Xiao H., Rath D. S., Merril C. R. Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res. 1991 Jan 11;19(1):195–195. doi: 10.1093/nar/19.1.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Purohit A., Ghilchik M. W., Duncan L., Wang D. Y., Singh A., Walker M. M., Reed M. J. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab. 1995 Oct;80(10):3052–3058. doi: 10.1210/jcem.80.10.7559896. [DOI] [PubMed] [Google Scholar]
  21. Santen R. J., Martel J., Hoagland M., Naftolin F., Roa L., Harada N., Hafer L., Zaino R., Santner S. J. Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab. 1994 Aug;79(2):627–632. doi: 10.1210/jcem.79.2.8045987. [DOI] [PubMed] [Google Scholar]
  22. Sasano H., Nagura H., Harada N., Goukon Y., Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol. 1994 May;25(5):530–535. doi: 10.1016/0046-8177(94)90127-9. [DOI] [PubMed] [Google Scholar]
  23. Sourdaine P., Parker M. G., Telford J., Miller W. R. Analysis of the aromatase cytochrome P450 gene in human breast cancers. J Mol Endocrinol. 1994 Dec;13(3):331–337. doi: 10.1677/jme.0.0130331. [DOI] [PubMed] [Google Scholar]
  24. Tan L., Muto N. Purification and reconstitution properties of human placental aromatase. A cytochrome P-450-type monooxygenase. Eur J Biochem. 1986 Apr 15;156(2):243–250. doi: 10.1111/j.1432-1033.1986.tb09574.x. [DOI] [PubMed] [Google Scholar]
  25. Tekmal R. R., Durgam V. R. The overexpression of int-5/Aromatase, a novel MMTV integration locus gene, is responsible for D2 mammary tumor cell proliferation. Cancer Lett. 1995 Jan 27;88(2):147–155. doi: 10.1016/0304-3835(94)03630-2. [DOI] [PubMed] [Google Scholar]
  26. Toda K., Shizuta Y. Molecular cloning of a cDNA showing alternative splicing of the 5'-untranslated sequence of mRNA for human aromatase P-450. Eur J Biochem. 1993 Apr 1;213(1):383–389. doi: 10.1111/j.1432-1033.1993.tb17772.x. [DOI] [PubMed] [Google Scholar]
  27. Toda K., Terashima M., Kawamoto T., Sumimoto H., Yokoyama Y., Kuribayashi I., Mitsuuchi Y., Maeda T., Yamamoto Y., Sagara Y. Structural and functional characterization of human aromatase P-450 gene. Eur J Biochem. 1990 Oct 24;193(2):559–565. doi: 10.1111/j.1432-1033.1990.tb19372.x. [DOI] [PubMed] [Google Scholar]
  28. Toda K., Yang L. X., Shizuta Y. Transcriptional regulation of the human aromatase cytochrome P450 gene expression in human placental cells. J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):181–190. doi: 10.1016/0960-0760(95)00032-u. [DOI] [PubMed] [Google Scholar]
  29. Trepicchio W. L., Krontiris T. G. IGH minisatellite suppression of USF-binding-site- and E mu-mediated transcriptional activation of the adenovirus major late promoter. Nucleic Acids Res. 1993 Feb 25;21(4):977–985. doi: 10.1093/nar/21.4.977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Utsumi T., Harada N., Maruta M., Takagi Y. Presence of alternatively spliced transcripts of aromatase gene in human breast cancer. J Clin Endocrinol Metab. 1996 Jun;81(6):2344–2349. doi: 10.1210/jcem.81.6.8964875. [DOI] [PubMed] [Google Scholar]
  31. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  32. Zhao Y., Mendelson C. R., Simpson E. R. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol Endocrinol. 1995 Mar;9(3):340–349. doi: 10.1210/mend.9.3.7776980. [DOI] [PubMed] [Google Scholar]
  33. Zhou C., Zhou D., Esteban J., Murai J., Siiteri P. K., Wilczynski S., Chen S. Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol. 1996 Oct;59(2):163–171. doi: 10.1016/s0960-0760(96)00100-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES